SterisFRA:2TG +11.53%90 FCF Margin % is 15.44% as of Mar. 2026, which is 27% above its 10-year median of 12.17. GuruFocus rates FRA:2TG with a GF Score™ of 90/100 and a GF Value™ of €238.39 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Steris ranks better than 86.01% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Steris's Free Cash Flow for the
three
months ended in Mar. 2026 was €212 Mil. Steris's Revenue for the
three
months ended in Mar. 2026 was €1,374 Mil. Therefore, Steris's FCF Margin % for the quarter that ended in Mar. 2026 was 15.44%.
The historical rank and industry rank for Steris's FCF Margin % or its related term are showing as below:
FRA:2TG'
s FCF Margin % Range Over the Past 10 Years
Min: 8.71 Med: 12.17 Max: 16.4
Current: 16.4
During the past 13 years, the highest FCF Margin % of Steris was 16.40%. The lowest was 8.71%. And the median was 12.17%.
FRA:2TG's FCF Margin % is ranked better than 86.01% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs FRA:2TG: 16.40
Steris FCF Margin % Related Terms
Steris FCF Margin % Historical Data
* Premium members only.
The historical data trend for Steris's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2TG vs ZBH, GEHC, DXCM: FCF Margin % Comparison
For the Medical Devices subindustry, Steris's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Steris's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (FRA:2TG) has a FCF Margin % of 15.44% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Steris and its competitors. This is 27% above median its historical median of 12.17. Over the past decade, Steris' FCF Margin % has ranged from 8.71 to 16.40. According to the industry distribution chart, Steris ranks #114 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is Steris' FCF Margin % too high?
Steris' current FCF Margin % of 15.44% is 27% above median its 10-year median of 12.17. Over the past 10 years, this metric has ranged from a low of 8.71 to a high of 16.40. Based on the distribution chart, Steris ranks #114 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Steris has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' FCF Margin % compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #114 out of 815 companies for FCF Margin %. This places Steris in the top 14% of its industry — outperforming the majority of peers. Historically, Steris' own FCF Margin % has ranged from 8.71 to 16.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Steris and its competitors. Steris's current FCF Margin % is 15.44%, which is 27% above median its own 10-year median of 12.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €238.39, compared to a current price of €183.80 — trading 22.9% below its estimated fair value. The current FCF Margin % is 15.44%, which is 27% above median its 10-year median of 12.17. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Steris (FRA:2TG), the current FCF Margin % is 15.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Steris (FRA:2TG) Overvalued in 2026?
Based on GuruFocus' analysis, Steris stock appears to be undervalued.
The current stock price of €183.80 is trading 22.9% below its estimated GF Value™ of €238.39.
GuruFocus considers Steris to be Modestly Undervalued.
Key valuation signals for FRA:2TG:
FCF Margin %: 15.44% (27% above median its 10-year median of 12.17)
GF Value™: €238.39 vs. price of €183.80 (22.9% below fair value)
No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score
Get the complete analysis for FRA:2TG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2TG has been successfully added to your 
